Cognitive Outcome of Acth-Treated Infantile Spasms
The long-term cognitive and seizure outcomes of 37 patients with cryptogenic infantile spasms (onset, age 3 to 9 months) treated with high-dose synthetic adrenocorticotropic hormone (ACTH) (1 mg IM every 48 hrs for 2 weeks, 8-10-week slow taper, followed by oral prednisone, 10 mg/d for 1 month, and...
| الحاوية / القاعدة: | Pediatric Neurology Briefs |
|---|---|
| المؤلف الرئيسي: | |
| التنسيق: | مقال |
| اللغة: | الإنجليزية |
| منشور في: |
Pediatric Neurology Briefs Publishers
2004-03-01
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://www.pediatricneurologybriefs.com/articles/1418 |
| _version_ | 1849715976872919040 |
|---|---|
| author | J Gordon Millichap |
| author_facet | J Gordon Millichap |
| author_sort | J Gordon Millichap |
| collection | DOAJ |
| container_title | Pediatric Neurology Briefs |
| description | The long-term cognitive and seizure outcomes of 37 patients with cryptogenic infantile spasms (onset, age 3 to 9 months) treated with high-dose synthetic adrenocorticotropic hormone (ACTH) (1 mg IM every 48 hrs for 2 weeks, 8-10-week slow taper, followed by oral prednisone, 10 mg/d for 1 month, and slow taper for 5 months or until age 1 year) were evaluated at Schneider Children’s Medical Center of Israel, Petah Tiqva, Israel. |
| format | Article |
| id | doaj-art-e02e23c859ef4210afe0e6d398dc4c5d |
| institution | Directory of Open Access Journals |
| issn | 1043-3155 2166-6482 |
| language | English |
| publishDate | 2004-03-01 |
| publisher | Pediatric Neurology Briefs Publishers |
| record_format | Article |
| spelling | doaj-art-e02e23c859ef4210afe0e6d398dc4c5d2025-08-20T01:55:07ZengPediatric Neurology Briefs PublishersPediatric Neurology Briefs1043-31552166-64822004-03-01183202110.15844/pedneurbriefs-18-3-51404Cognitive Outcome of Acth-Treated Infantile SpasmsJ Gordon Millichap0Northwestern University Feinberg School of MedicineThe long-term cognitive and seizure outcomes of 37 patients with cryptogenic infantile spasms (onset, age 3 to 9 months) treated with high-dose synthetic adrenocorticotropic hormone (ACTH) (1 mg IM every 48 hrs for 2 weeks, 8-10-week slow taper, followed by oral prednisone, 10 mg/d for 1 month, and slow taper for 5 months or until age 1 year) were evaluated at Schneider Children’s Medical Center of Israel, Petah Tiqva, Israel.https://www.pediatricneurologybriefs.com/articles/1418adrenocorticotropic hormoneinfantile spasmsearly treatment group |
| spellingShingle | J Gordon Millichap Cognitive Outcome of Acth-Treated Infantile Spasms adrenocorticotropic hormone infantile spasms early treatment group |
| title | Cognitive Outcome of Acth-Treated Infantile Spasms |
| title_full | Cognitive Outcome of Acth-Treated Infantile Spasms |
| title_fullStr | Cognitive Outcome of Acth-Treated Infantile Spasms |
| title_full_unstemmed | Cognitive Outcome of Acth-Treated Infantile Spasms |
| title_short | Cognitive Outcome of Acth-Treated Infantile Spasms |
| title_sort | cognitive outcome of acth treated infantile spasms |
| topic | adrenocorticotropic hormone infantile spasms early treatment group |
| url | https://www.pediatricneurologybriefs.com/articles/1418 |
| work_keys_str_mv | AT jgordonmillichap cognitiveoutcomeofacthtreatedinfantilespasms |